Xconomy: Affinivax News, Articles and Opinions

Entry	Author	Date	Location
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies	Frank Vinluan	03/21/17	San Francisco
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More	Alex Lash	03/03/17	National
Affinivax Obtains $2,500,000 New Funding Round	VentureDeal	02/05/16	Boston
Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall	Ben Fidler	10/19/15	Boston
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More	Ben Fidler	02/13/15	Boston
Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software	Ben Fidler	12/16/14	New York
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More	Ben Fidler	10/31/14	Boston
Affinivax Garners $4,000,000 New Round	VentureDeal	10/31/14	Boston
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech	Ben Fidler	10/30/14	Boston
Page 1 of 1

Xpertise: Watch + Learn

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems